Site icon AISC


Introducing the AISC Consortium

AISC is a research consortium with a vision of producing clinically applicable research in the field of skin and mole cancer diagnostics. In a collaboration between private and public, national and international, AISC seeks to develop an evidence-based clinically implementable tool for healthcare professionals that diagnose and treat skin cancer.
A paradigm shift that reinforces the focus of the clinical routine from production to learning.

6 years of education in 2 months

With shared data, expert-reviewed learning materials and an AI augmented digital mentor that optimizes the learning material for each user, the doctor can learn in two months what would have otherwise taken 6 years.

The change

AISC will investigate the effect of the introduction of a smartphone-based educational platform that allows easy follow-up and where the clinical feedback is continues, systematic and timesaving.

Current standard of practice leaves little room for actual learning and very few clinicians have time to follow up on previous patients. This leads to a loss of valuable clinical learning for each doctor. We wish to iterate that fact by fusing work, documentation and clinical feedback.

By far most skin lesions seen in the GP’s office are benign with no need for referral to the dermatologist and no need for surgical intervention. The most important treatment for the patient in most cases is reassurance. With an improved diagnostic accuracy this can be given in more cases initially, instead of the patient having to be seen by any other doctors.

A picture is worth a thousand words

To us, thousands of pictures are worth more than mere words. By letting the clinician systematically photo-document and diagnose his or her patients’ skin lesions and learning from thousands of other cases, we will teach an AI to help accelerate the learning curve for each participating doctor.

Eventually the growing library of annotated pictures of skin lesions will teach an AI to support the clinician in his or her diagnosis, right there with the patient waiting. Thereby avoiding most referrals to the dermatologist.

Mission and Vision

AISC wants to enable doctors to diagnose skin and mole cancer correctly and quickly and minimize the amount of removed benign skin lesions.

To reach that goal, the AISC Research Consortium wants to make patient data benefit doctors and patients alike, but with complete anonymity and safety. We see no reason for each doctor to having to learn seeing one patient at a time, making his or her own mistakes that thousands of other doctors have done before.

Correctly separating melanoma from atypical nevi is challenging, and the result is the referral of an overabundance of benign skin lesions. AISC is trying to reduce the amount of defensive medical actions that are being taking by doctors.
Can the use of a teledermatological second opinion and an accurate and easy follow-up function reduce the amount of benign referrals and speed up the time from diagnosis to treatment for the patients with actual malignancy?

We will reduce the amount of excised benign skin lesions and help allocate the scares recourses to where they actually matter. We want to raise the diagnostic competence of all doctors that diagnose and treat skin and mole cancer, for the benefit the patient, for the doctor that can feel uncertain about the decisions made and for society as a whole.

Gustav Gede Nervil, AISC Researcher

The doctors and clinician can use every skin lesion seen as a possibility for education and clinical feedback, from the dermatologist, the plastic surgeon and/or the pathologists.

And not just education for one self, but for colleagues, students and future colleagues.

The current “Gold Standard” in diagnosing melanoma and skin cancer is the histopathological evaluation. This method of evaluation has a high, but not perfect sensitivity or specificity.
As a side project AISC is investigating if an AI enhanced diagnostic tool can introduce a more precise measurement to either replace or augment the current histopathological evaluation.

AISC Timeline

Contact Us


+45 3868 9236

Find Us

The Research Unit at the Department of Plastic Surgery
Ground Floor, Entrance 7
Herlev Hospital
Borgmester Ib Juuls Vej 7
2730 Herlev

Follow us

Exit mobile version